BSX241025P84000
- 0.03
- -0.07-70.00%
Boston Scientific Newsroom
Internet of Medical Things (IoMT) Market Report 2024-2034, Featuring Profiles of Baxter, Bio Techne, Biotronik, Boston Scientific, Cisco Systems, GE Healthcare, IBM, Medtronic, Siemens and More
C.L. King Maintains Boston Scientific(BSX.US) With Buy Rating, Raises Target Price to $90
Weekly Buzz: Is Tesla a sign of earnings to come?
Friday Market Falls With Busy Business Ahead | Wall Street Today
Catalyst Watch: Eyes on Tech With Apple, Amazon, Alphabet, and Meta Reporting
Mooer's Stories | How Stock_Drift Navigates Irrational Markets
Friday Market Climbs After Big Earnings, and More to Come | Live Moovin' Stocks
Medtronic' Affera, Sphere-9 Offering Is Threat to Boston Scientific -- Market Talk
TD Cowen Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $100
Argus Adjusts Price Target on Boston Scientific to $105 From $90
Today's Analyst Rating | KeyBanc Downgrades Apple to Sell, T-Mobile US Price Target Raised to $230 by Barclays
Medtronic Gets FDA Okay for Affera Mapping and Ablation System
NICE Recommends Boston Scientific HeartLogic Tech for Managing People With Cardiac Implants
Baird Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $100
Promising Growth Prospects for Boston Scientific Amid Short-Term Risks and Strategic Acquisitions
Boston Scientific Price Target Maintained With a $98.00/Share by Canaccord Genuity
Boston Scientific Is Maintained at Buy by Canaccord Genuity
A Quick Look at Today's Ratings for Boston Scientific(BSX.US), With a Forecast Between $97 to $100
Daily short sale tracking: NVIDIA's short volume increased by 5 million, with a short sale ratio of 7%
Express News | Mizuho Maintains Outperform on Boston Scientific, Raises Price Target to $110